Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$139.25K

Rothblatt Martine A Chairperson & CEO

Transaction date Aug 21, 2026
Public filing date Aug 24, 2026
Filing lag Filed 3 days later

UTHR daily price context

Close on/before transaction
$513.12 Aug 21, 2026
First close after public filing
$518.53 Aug 25, 2026
30-day return after filing
-5.61% Through Sep 23, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
271 shares @ $513.85
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000126
Filing cohort

Transactions in this filing

Showing 15 of 17
Trades
17
Issuers
1
Estimated value
$6.21M
Buys / sales
0 / 15
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Aug 21, 2026 $193.4K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $238.25K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $105.54K
United Therapeutics Corp UTHR Exercise Aug 21, 2026 $1.29M
United Therapeutics Corp UTHR Sale Aug 21, 2026 $609.62K
United Therapeutics Corp UTHR Current Sale Aug 21, 2026 $139.25K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $321.52K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $871.78K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $399.69K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $558.03K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $434.47K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $228.81K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $349.41K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $327.72K
United Therapeutics Corp UTHR Sale Aug 21, 2026 $123.47K